Improved Survival Trends in Platinum-Resistant Patients with Advanced Ovarian, Fallopian or Peritoneal Cancer Treated with First-Line Paclitaxel/Platinum Chemotherapy: The Impact of Novel Agents — Aristotle Bamias (2012) | RDL Network
Improved Survival Trends in Platinum-Resistant Patients with Advanced Ovarian, Fallopian or Peritoneal Cancer Treated with First-Line Paclitaxel/Platinum Chemotherapy: The Impact of Novel Agents
Article 2012 en
Authors
AB
Aristotle Bamias
CB
Christine Bamia
FZ
Flora Zagouri
Abstract
1 min read
The introduction of novel agents without cross-resistance to platinum or taxanes has improved the prognosis of platinum-resistant patients.
Dimosthenis Skarlos, Haralabos P. Kalofonos, George Fountzilas, Meletios A Dimopoulos, Nicholas Pavlidis, E. Razis, Theofanis Economopoulos, Dimitrios Pectasides, Helen Gogas, P. Kosmidis, Dimitrios Bafaloukos, G. Klouvas, George Kyratzis, Gerasimos Aravantinos
Discussion(0)
No comments yet. Be the first to comment.